ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING Clinical Program
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.5.supp.62
◽
2021
◽
Vol 5
(6)
◽
pp. s62
Author(s):
Lawrence Eichenfeld
◽
Jonathan Silverberg
◽
Robert Bissonnette
◽
Anna Tallman
◽
David Rubenstein
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
◽
Once Daily
◽
Clinical Program
N/A
Download Full-text
Related Documents
Cited By
References
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)
SSRN Electronic Journal
◽
10.2139/ssrn.3748383
◽
2020
◽
Author(s):
Kristian Reich
◽
Henrique D. Teixeira
◽
Marjolein de Bruin-Weller
◽
Thomas Bieber
◽
Weily Soong
◽
...
Keyword(s):
Atopic Dermatitis
◽
Controlled Study
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
◽
Double Blind
◽
Safety And Efficacy
◽
Double Blind Placebo
◽
Topical Corticosteroids
◽
Adolescents And Adults
Download Full-text
Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.98
◽
2020
◽
Vol 4
(6)
◽
pp. s98
Author(s):
Jonathan I. Silverberg
◽
Michael Cork
◽
Andreas Wollenberg
◽
Norito Katoh
◽
Louise Abildgaard Steffensen
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
Abstract not available.
Download Full-text
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
The Lancet
◽
10.1016/s0140-6736(21)00588-2
◽
2021
◽
Cited By ~ 1
Author(s):
Emma Guttman-Yassky
◽
Henrique D Teixeira
◽
Eric L Simpson
◽
Kim A Papp
◽
Aileen L Pangan
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Double Blind
◽
Once Daily
◽
Adolescents And Adults
◽
Randomised Controlled
Download Full-text
27082 Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.06.534
◽
2021
◽
Vol 85
(3)
◽
pp. AB129
Author(s):
Emma Guttman-Yassky
◽
Alan D. Irvine
◽
Jonathan I. Silverberg
◽
Kim A. Papp
◽
Amy S. Paller
◽
...
Keyword(s):
Atopic Dermatitis
◽
Safety Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Asthma: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
Journal of Allergy and Clinical Immunology
◽
10.1016/j.jaci.2017.12.420
◽
2018
◽
Vol 141
(2)
◽
pp. AB132
Author(s):
Mette Deleuran
◽
Emma Guttman-Yassky
◽
Kulli Kingo
◽
Neil M.H. Graham
◽
Gianluca Pirozzi
◽
...
Keyword(s):
Atopic Dermatitis
◽
Pooled Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
Journal of Allergy and Clinical Immunology
◽
10.1016/j.jaci.2017.12.418
◽
2018
◽
Vol 141
(2)
◽
pp. AB131
Author(s):
Eric L. Simpson
◽
Jean-Philippe Lacour
◽
Jonathan I. Silverberg
◽
Margitta Worm
◽
Andreas Wollenberg
◽
...
Keyword(s):
Atopic Dermatitis
◽
Food Allergy
◽
Pooled Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
ESDR084 - Herpes virus infections amongst moderate to severe atopic dermatitis patients treated with baricitinib: an integrated analysis of phase 3 trials
10.26226/morressier.61081ff8bc981037240fe3dd
◽
2021
◽
Author(s):
Thomas Werfel
Keyword(s):
Atopic Dermatitis
◽
Herpes Virus
◽
Integrated Analysis
◽
Severe Atopic Dermatitis
◽
Virus Infections
◽
Phase 3
◽
Herpes Virus Infections
◽
Herpès Virus
Download Full-text
Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
Journal of Allergy and Clinical Immunology
◽
10.1016/j.jaci.2019.12.267
◽
2020
◽
Vol 145
(2)
◽
pp. AB191
Author(s):
Lawrence Sher
◽
Weily Soong
◽
Paola Mina-Osorio
◽
Randy Prescilla
◽
Zhen Chen
◽
...
Keyword(s):
Allergic Rhinitis
◽
Atopic Dermatitis
◽
Subgroup Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
History Of
Download Full-text
15054 Impact of baricitinib on patient-reported skin symptoms, itch, and quality of life in adult patients with moderate to severe atopic dermatitis and an inadequate response to topical therapies from phase 3 trials BREEZE-AD1 and BREEZE-AD2
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2020.06.198
◽
2020
◽
Vol 83
(6)
◽
pp. AB28
Author(s):
Peter Lio
◽
Audrey Nosbaum
◽
Tracy Cardillo
◽
Amy DeLozier
◽
Margaret Gamalo
◽
...
Keyword(s):
Quality Of Life
◽
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Inadequate Response
◽
Phase 3
◽
Skin Symptoms
◽
Patient Reported
Download Full-text
16405 Abrocitinib treatment in patients with moderate to severe atopic dermatitis: Consistency of efficacy responses from randomized, controlled phase 3 and phase 2b clinical trials
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2020.06.336
◽
2020
◽
Vol 83
(6)
◽
pp. AB62
Author(s):
Eric L. Simpson
◽
Melinda Gooderham
◽
Brett King
◽
Susan C. Taylor
◽
David Rosmarin
◽
...
Keyword(s):
Clinical Trials
◽
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Randomized Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close